SPO Global Inc. (SPOM) Research

Established in 2006 and headquartered in Jinan, China, Gerpang Healthcare Group operates as a bio-pharmaceutical enterprise. The company focuses on developing and marketing a diverse range of products, including genetically coated stents, vaccines for the Hepatitis B virus (HBV), monoclonal antibodies designed to detect male infertility, functional foods targeting cognitive disorders, and polypeptide-based probiotics.

Market snapshot

Symbol
SPOM
Price
$0.00
Day change
0.00%
Market cap
$69.3K
P/E ratio
-2.37x
52-week range
0.0002-0.00134
Sector
Technology
Industry
Software - Application

Peer companies

  • AiAdvertising, Inc. (AIAD)
  • Monster Arts, Inc. (APPZ)
  • bowmo, Inc. (BOMO)
  • eFUEL EFN, Corp. (EFLN)
  • Flitways Technology Inc. (FTWS)
  • Global Arena Holding Inc. (GAHC)
  • SponsorsOne Inc. (SPONF)
  • The Pulse Network, Inc. (TPNI)

Open SPO Global Inc. (SPOM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.